بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
greater decrease » greatest decrease (توسيع البحث), greater increase (توسيع البحث), greater disease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
greater decrease » greatest decrease (توسيع البحث), greater increase (توسيع البحث), greater disease (توسيع البحث)
-
1801
-
1802
Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components.
منشور في 2025الموضوعات: -
1803
-
1804
Cinnamaldehyde repellency test within 6 hours in parthenogenesis <i>H. longicornis.</i>
منشور في 2025الموضوعات: -
1805
Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription...
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
1806
Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n...
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
1807
Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019.
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
1808
Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
1809
Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8...
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
1810
Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
1811
UTI diagnoses by sex and physician specialty (2013–2019).
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
1812
Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste...
منشور في 2025"…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…"
-
1813
Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste...
منشور في 2025"…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…"
-
1814
Quality of life and Beck Depression Inventory baseline and post CRT+MRT, CRT and RUHB.
منشور في 2024الموضوعات: -
1815
-
1816
-
1817
ΔQuality of life and ΔBeck Depression Inventory baseline and post CRT+MRT, CRT and RUHB.
منشور في 2024الموضوعات: -
1818
-
1819
-
1820